COGNICURRENT

Brazil's health regulatory agency Anvisa is currently reviewing eight semaglutide-based drug applications following the recent patent expiration of the popular medications Ozempic and Wegovy.

A pharmacist in Bragança Paulista, Brazil, has been arrested for allegedly selling psychiatric and weight loss medications without prescriptions and violating health regulations.

Brazil's Anvisa agency has partially closed a compounding pharmacy in São José dos Campos due to sanitary irregularities.

The patent for semaglutide, used in medications like Ozempic, expires soon, but Brazil has yet to see affordable national alternatives, with new versions anticipated by June after regulatory approvals.

The patent for semaglutide, the active ingredient in Ozempic and Wegovy, expires, allowing other companies to manufacture and sell similar medications in Brazil.

Brazil's Anvisa has approved a multidose version of the diabetes and obesity medication Mounjaro, allowing for multiple uses from a single vial.

Anvisa seized various health-related products at a Mercado Livre logistics center in Brazil during a regulatory inspection.

The Brazilian health agency Anvisa has suspended the sale, distribution, and use of three specific batches of Aptamil infant formula after the detection of a toxin.

Anvisa has seized irregular medical devices, cosmetics, and food items during an inspection at a Mercado Livre logistics center in Brazil.

Brazil's health regulatory agency, Anvisa, has approved a new multidose version of the diabetes medication Mounjaro, allowing patients to use a single pen for multiple doses.

State deputies in Roraima have overridden the governor's veto on a law regulating the use of artificial tanning beds, which are banned by national health authorities due to cancer risks.

Anvisa has prohibited the sale and ordered the recall of all lots of extra virgin olive oil from the San Olivetto brand due to questions regarding its origin.

Brazil's Anvisa has mandated the recall of gel nail polishes from Impala due to the presence of a prohibited ingredient linked to fertility issues.

Brazil's health regulatory agency, Anvisa, has ordered the recall of Impala gel nail polishes due to the presence of a substance that has been banned in cosmetic products.

The Brazilian government has banned the sale of San Olivetto olive oil due to irregularities and unknown origins of the product.

A patient with spinal injury who regained the ability to walk has sparked hope and legal actions for early access to a drug called polylaminin, currently in research phases.

Anvisa has ordered the seizure of tirzepatide products produced irregularly by El Elyon de Manipulação Ltda in Brazil.

Eighteen tanning beds, banned in Brazil for causing skin cancer, were seized in aesthetic clinics in Boa Vista after a client reported severe burns during a session.

Brazil's health agency Anvisa has approved XCOPRI (cenobamato), a medication expected to significantly improve treatment options for severe epilepsy crises.

A doctor was arrested for smuggling weight loss medications on BR-459 in Pouso Alegre, Brazil.

Anvisa has approved teplizumab, a medication that can potentially postpone the onset of type 1 diabetes for patients aged 8 and older in Brazil.

The Brazilian health agency Anvisa has approved a new medication that may help delay the progression of type 1 diabetes in patients.

Brazilian pharmaceutical EMS aims to introduce its generic version of Ozempic to the market by September, contingent on the approval from health agency Anvisa within the next 60 days.

The Federal Highway Police seized 37 ampoules of a banned appetite suppressant medication in Caruaru, Pernambuco, which was found hidden in the ceiling of an uncooled vehicle.

The Brazilian health agency Anvisa warns that turmeric supplements may lead to liver inflammation and damage, urging warnings on products containing high doses of this compound.

Brazil's health regulatory agency Anvisa has issued a warning about the rare risk of liver inflammation and damage connected to the use of turmeric supplements, especially in concentrated forms.

Mass manipulation of weight control medications poses significant health risks as it operates outside of necessary regulatory oversight.

A supplier of Brazil's Ministry of Health exported a banned immunoglobulin shipment to Panama, linked to an investigation into money laundering and organized crime.

Brazil's health regulatory agency, Anvisa, has approved a new medication for hemophilia that potentially reduces bleeding episodes.

Anvisa has banned Vita BE Cosméticos from selling sublingual melatonin due to safety concerns and misleading advertising claims.

Brazil's Anvisa has suspended the sale and distribution of two dietary supplements due to the absence of required stability studies.

Palmitos Lemos must present a collection plan for their products within 48 hours following an ANVISA decision, with fines potentially reaching R$1.5 million for non-compliance.

There has been a surge of over 5,000 people seeking polylaminin from Cristália and the courts, raising concerns among neurosurgeons about the substance's safety due to unverified efficacy.

A 19-year-old man was arrested in Olinda for selling banned weight loss pens at a college parking lot.

The Brazilian government has banned the sale of the Palmito Lemos brand due to lack of sanitary licensing and compliance with production standards.

A lawsuit has been filed against Ipê Clube in São Paulo for using unregistered chemical products in its swimming pools, prompting city inspections and the temporary replacement of the products.

A supplier for Brazil's Unified Health System (SUS) secured R$ 30 million from a company under investigation for alleged organized crime connections.

Anvisa has banned over 150 intimate gels and erotic extracts from being sold due to lack of proper registration and safety evaluations.

A groundbreaking Brazilian study on polylaminin shows promising results in restoring movement after severe injuries, with a pivotal clinical study approved by Anvisa set to begin next month.

The Brazilian health regulator Anvisa has ordered the recall and immediate suspension of the injectable antibiotic Kefadim due to a packaging error that led to the mislabeling of its contents.

The National Health Surveillance Agency (Anvisa) in Brazil has introduced new regulations to facilitate the cultivation of cannabis and improve research opportunities.

Anvisa has reported 65 notifications of suspected deaths related to the use of weight loss medications known as pens between December 1, 2018, and December 7, 2025.

Brazil's health regulatory agency Anvisa has seized counterfeit batches of several drugs including Mounjaro and prohibited the compounding of hormonal implants.

The Brazilian health agency's recent measures to regulate the use and cultivation of medicinal cannabis are criticized for lacking robust scientific evidence and potentially leading to increased drug dependence and crime.

Brazil's health regulatory agency, Anvisa, reports 65 suspected deaths linked to the use of weight loss pens from December 2018 to December 2025, with a significant increase in reported adverse events.

Compounding pharmacies in Brazil are reportedly offering illegal weight loss injection sales to doctors, along with profit-sharing proposals.

Brazil's National Health Surveillance Agency (Anvisa) is expected to announce its decision regarding the registration of national versions of semaglutide-based pens, essential for diabetes treatment, next week.

Anvisa, Brazil's health regulatory agency, is expected to make a decision in the coming weeks regarding the approval of two competitors to Ozempic and Wegovy, as the substance semaglutide loses its patent.

Brazil's health agency warns about the risks of using weight loss pens without medical supervision, highlighting potential severe side effects.

Anvisa has approved guidelines to allow electronic issuance of controlled prescriptions in Brazil, set to be implemented on June 1.